© 1993 Oxford University Press
other |
The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung
1Department of Industrial Hygiene and Toxicology, Institute of Occupational Health 00250 Helsinki, Finland
2International Agency for Research on Cancer 69372 Lyon, France
The identification of genetic traits that predispose individuals to environmentally induced cancers is one of the challenges in the assessment of individual cancer risk. For this reason, individual variations in the expression of enzymes involved in biotransformation reactions have been extensively studied. One such polymorphic enzyme is GSTM1, which belongs to the class Mu of glutathione S-transferases (GSTs), and is only expressed in 55–60% of Caucasians. Previous data suggest that smokers lacking GSTM1activity may be at greater risk of developing lung cancer. In this study, we used a polymerase chain reaction-based method to examine this issue in a Finnish study population. We found that 44% of a control group of 142 individuals lacked the GSTM1 gene, i.e. they had the GSTM1 null genotype; the rest were either homozygous or heterozygous for the expressed GSTM1 alleles. In a group of 36 patients with non-neoplastic pulmonary diseases, an identical distribution was observed. However, among 138 lung cancer patients the distribution of the GSTM1 genotypes deviated from that found in the healthy controls (53% nulled; odds ratio 1.5, 95% confidence interval 0.9–2.3). Furthermore, when the lung cancer patients were analysed by tumour type, a statistically significant increase in the GSTM1 null genotypes (62%; n = 71) was seen in the squamous cell carcinoma group, with an odds ratio of 2.1 (95% confidence interval 1.2–3.8). These data support the suggestion that GSTM1 null genotype may act as a risk modifier in lung cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. A. Hakim, H.-H. S. Chow, and R. B. Harris Green Tea Consumption Is Associated with Decreased DNA Damage among GSTM1-Positive Smokers Regardless of Their hOGG1 Genotype J. Nutr., August 1, 2008; 138(8): 1567S - 1571S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-M. Lee, D. Kang, M. L. Clapper, M. Ingelman-Sundberg, M. Ono-Kihara, C. Kiyohara, S. Min, Q. Lan, L. Le Marchand, P. Lin, et al. CYP1A1, GSTM1, and GSTT1 Polymorphisms, Smoking, and Lung Cancer Risk in a Pooled Analysis among Asian Populations Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1120 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, Y. Bai, J. Yuan, W. Chen, J. Sun, H. Wang, H. Liang, L. Guo, X. Yang, H. Tan, et al. Association of Polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 Genes with Levels of DNA Damage in Peripheral Blood Lymphocytes among Coke-Oven Workers. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1703 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Montero, L. Serrano, A. Araujo, V. Davila, J. Ponce, R. Camacho, E. Morales, and A. Mendez Increased cytogenetic damage in a zone in transition from agricultural to industrial use: comprehensive analysis of the micronucleus test in peripheral blood lymphocytes Mutagenesis, September 1, 2006; 21(5): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S-L. Cheng, C-J. Yu, C-J. Chen, and P-C. Yang Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD Eur. Respir. J., June 1, 2004; 23(6): 818 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Hakim, R. B. Harris, H-H. S. Chow, M. Dean, S. Brown, and I. U. Ali Effect of a 4-Month Tea Intervention on Oxidative DNA Damage among Heavy Smokers: Role of Glutathione S-Transferase Genotypes Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Barnette, R. Scholl, M. Blandford, L. Ballard, A. Tsodikov, J. Magee, S. Williams, M. Robertson, F. Ali-Osman, R. Lemons, et al. High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 304 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Chen, L. S. Chang, H.-W. Chen, and Y.-H. Wei Polymorphisms of glutathione S-transferase M1 and male infertility in Taiwanese patients with varicocele Hum. Reprod., March 1, 2002; 17(3): 718 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stucker, P. Boffetta, S. Antilla, S. Benhamou, A. Hirvonen, S. London, and E. Taioli Lack of Interaction between Asbestos Exposure and Glutathione S-Transferase M1 and T1 Genotypes in Lung Carcinogenesis Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1253 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Ford, Y. Li, M. M. O'Sullivan, R. Demopoulos, S. Garte, E. Taioli, and P. W. Brandt-Rauf Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans Carcinogenesis, November 1, 2000; 21(11): 1971 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cascorbi, S. Henning, J. Brockmöller, J. Gephart, C. Meisel, J. M. Müller, R. Loddenkemper, and I. Roots Substantially Reduced Risk of Cancer of the Aerodigestive Tract in Subjects with Variant -463A of the Myeloperoxidase Gene Cancer Res., February 1, 2000; 60(3): 644 - 649. [Abstract] [Full Text]
|
|
|
|
|
|
L.J. Hardie, J.A. Briggs, L.A. Davidson, J.M. Allan, R.F.G.J. King, G.I. Williams, and C.P. Wild The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer Carcinogenesis, February 1, 2000; 21(2): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Yim, G. Y. Park, C.-T. Lee, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-G. Yoo Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1 Thorax, February 1, 2000; 55(2): 121 - 125. [Abstract] [Full Text]
|
|
|
|
|
|
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis, January 1, 2000; 21(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Hou, D. Ryberg, S. Falt, A. Deverill, T. Tefre, A.-L. Borresen, A. Haugen, and B. Lambert GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients Carcinogenesis, January 1, 2000; 21(1): 49 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Woodson, C. Stewart, M. Barrett, N. K. Bhat, J. Virtamo, P. R. Taylor, and D. Albanes Effect of Vitamin Intervention on the Relationship between GSTM1, Smoking, and Lung Cancer Risk Among Male Smokers Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 965 - 970. [Abstract] [Full Text]
|
|
|
|
|
|
M. Sato, T. Sato, T. Izumo, and T. Amagasa Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer Carcinogenesis, October 1, 1999; 20(10): 1927 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Houlston Glutathione S-Transferase M1 Status and Lung Cancer Risk: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 675 - 682. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chen and W. Nirunsuksiri Decreased expression of glutathione S-transferase M1 in HPV16-transfected human cervical keratinocytes in culture Carcinogenesis, April 1, 1999; 20(4): 699 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Stroombergen and R. H Waring Determination of glutathione S-transferase {micro} and {tau} polymorphisms in neurological disease Human and Experimental Toxicology, March 1, 1999; 18(3): 141 - 145. [Abstract] [PDF]
|
|
|
|
|
|
E. M. M. van Lieshout, H. M. J. Roelofs, S. Dekker, C. J. J. Mulder, T. Wobbes, J. B. M. J. Jansen, and W. H. M. Peters Polymorphic Expression of the Glutathione Polymorphic Expression of the Glutathione S-Transferase P1 Gene and Its Susceptibility to Barrett's Esophagus and Esophageal Carcinoma Cancer Res., February 1, 1999; 59(3): 586 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Van schooten, A. Hirvonen, L. M. Maas, B. A. De mol, J. C. S. kleinjans, D. A. Bell, and J. D. Durrer Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue FASEB J, October 1, 1998; 12(13): 1409 - 1417. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.-j. Xu, Y.-p. Wang, B. Roe, and W. R. Pearson Characterization of the Human Class Mu Glutathione S-Transferase Gene Cluster and the GSTM1 Deletion J. Biol. Chem., February 6, 1998; 273(6): 3517 - 3527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. McLellan, M. Oscarson, A.-K. Alexandrie, J. Seidegård, D. A. P. Evans, A. Rannug, and M. Ingelman-Sundberg Characterization of a Human Glutathione S-Transferase µ Cluster Containing a Duplicated GSTM1 Gene that Causes Ultrarapid Enzyme Activity Mol. Pharmacol., December 1, 1997; 52(6): 958 - 965. [Abstract] [Full Text]
|
|